Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$62.17 - $97.62 $93,379 - $146,625
-1,502 Reduced 13.17%
9,900 $966,000
Q4 2022

Feb 14, 2023

SELL
$60.21 - $77.74 $57,741 - $74,552
-959 Reduced 7.76%
11,402 $708,000
Q3 2022

Nov 15, 2022

SELL
$72.92 - $99.73 $63,950 - $87,463
-877 Reduced 6.62%
12,361 $901,000
Q2 2022

Aug 15, 2022

BUY
$84.23 - $147.57 $27,458 - $48,107
326 Added 2.52%
13,238 $1.25 Million
Q1 2022

May 13, 2022

BUY
$122.89 - $171.74 $14,132 - $19,750
115 Added 0.9%
12,912 $1.79 Million
Q4 2021

Feb 14, 2022

BUY
$156.0 - $265.78 $2,808 - $4,784
18 Added 0.14%
12,797 $2.34 Million
Q3 2021

Nov 10, 2021

SELL
$228.69 - $274.2 $105,197 - $126,132
-460 Reduced 3.47%
12,779 $3.3 Million
Q2 2021

Jul 30, 2021

BUY
$169.89 - $231.37 $657,304 - $895,170
3,869 Added 41.29%
13,239 $3.04 Million
Q1 2021

May 06, 2021

BUY
$143.93 - $207.3 $57,572 - $82,920
400 Added 4.46%
9,370 $1.58 Million
Q3 2020

Nov 12, 2020

SELL
$90.16 - $107.61 $18,032 - $21,522
-200 Reduced 2.18%
8,970 $886,000
Q2 2020

Aug 13, 2020

BUY
$52.17 - $95.63 $27,128 - $49,727
520 Added 6.01%
9,170 $854,000
Q4 2019

Feb 18, 2020

BUY
$69.39 - $97.59 $3,469 - $4,879
50 Added 0.58%
8,650 $830,000
Q3 2019

Nov 14, 2019

SELL
$64.17 - $84.08 $96,255 - $126,120
-1,500 Reduced 14.85%
8,600 $609,000
Q2 2019

Aug 14, 2019

BUY
$70.1 - $85.17 $196,279 - $238,476
2,800 Added 38.36%
10,100 $860,000
Q2 2018

Aug 13, 2018

SELL
$74.5 - $108.91 $16,464 - $24,069
-221 Reduced 2.94%
7,300 $758,000
Q1 2018

May 14, 2018

BUY
$58.36 - $83.18 $77,093 - $109,880
1,321 Added 21.31%
7,521 $595,000
Q4 2017

Feb 13, 2018

SELL
$77.49 - $98.41 $727,631 - $924,069
-9,390 Reduced 60.23%
6,200 $497,000
Q3 2017

Nov 13, 2017

BUY
$84.87 - $109.54 $1.32 Million - $1.71 Million
15,590
15,590 $1.37 Million

Others Institutions Holding HSKA

About HESKA CORP


  • Ticker HSKA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 10,818,900
  • Description
  • Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...
More about HSKA
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.